Sight Sciences Announces the Acceptance for Publication of GEMINI 2, a Three Year, Prospective, Multicenter Trial Demonstrating Sustained, Significant IOP and Medication Reductions Enabled with the OMNI® Surgical System Technology

December 15, 2023

https://www.globenewswire.com/news-release/2023/12/08/2793174/0/en/Sight-Sciences-Announces-the-Acceptance-for-Publication-of-GEMINI-2-a-Three-Year-Prospective-Multicenter-Trial-Demonstrating-Sustained-Significant-IOP-and-Medication-Reductions-Ena.html

Prospective, long-term trial results are consistent with the significant body of published clinical evidence demonstrating the durable safety and effectiveness of procedures enabled with the OMNI Surgical System technology

Read more at globenewswire.com

Related news for (SGHT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.